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Abstract
Bifidobacterium longum subsp. infantis (B. infantis) is a common member of the infant intestinal microbiota, and it has been
characterized by its foraging capacity for human milk oligosaccharides (HMO). Its genome sequence revealed an
overabundance of the Family 1 of solute binding proteins (F1SBPs), part of ABC transporters and associated with the import
of oligosaccharides. In this study we have used the Mammalian Glycan Array to determine the specific affinities of these
proteins. This was correlated with binding protein expression induced by different prebiotics including HMO. Half of the
F1SBPs in B. infantis were determined to bind mammalian oligosaccharides. Their affinities included different blood group
structures and mucin oligosaccharides. Related to HMO, other proteins were specific for oligomers of lacto-N-biose (LNB)
and polylactosamines with different degrees of fucosylation. Growth on HMO induced the expression of specific binding
proteins that import HMO isomers, but also bind blood group and mucin oligosaccharides, suggesting coregulated
transport mechanisms. The prebiotic inulin induced other family 1 binding proteins with affinity for intestinal glycans. Most
of the host glycan F1SBPs in B. infantis do not have homologs in other bifidobacteria. Finally, some of these proteins were
found to be adherent to intestinal epithelial cells in vitro. In conclusion, this study represents further evidence for the
particular adaptations of B. infantis to the infant gut environment, and helps to understand the molecular mechanisms
involved in this process.
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Introduction
The distal portion of the human gastrointestinal tract is
colonized by an impressive number of microorganisms, which
are collectively referred as the intestinal microbiota. The
environment they occupy is considered to be rich in complex
dietary and host-derived oligosaccharides, which serve as an
important carbon source for many of these microbes. In general,
members of the intestinal microbiota devote an important
percentage of their genomes to the utilization of complex
carbohydrates [1,2]. This specialization requires specific intra or
extracellular glycosyl hydrolases to break down the complex
oligosaccharides arriving to the colon, and also transport
mechanisms to import intact or processed glycans inside the
bacterial cell. Bacterial ABC transporters involved in the import of
oligosaccharides show an exquisite specificity, conferred by Solute
Binding Proteins (SBPs) [3].
Bifidobacterium species represent an important percentage of the
total colonic microbiota in infants [4], and they remain at
significant levels in adults [5]. In general they are considered
beneficial microorganisms. Some strains in this genus are
noteworthy as probiotics, and they represent one of the main
targets in prebiotic interventions [6]. In particular, bifidobacteria
are efficient in the utilization of complex oligosaccharides, such as
fructo-oligosaccharides (FOS) [7], galacto-oligosaccharides (GOS)
[8] and inulin [9].
In the last decades several studies have associated breast-
feeding with higher concentrations of bifidobacteria in infant
feces [10,11]. Formula fed infants seem to have lower numbers
of Bifidobacterium, even though it has been argued that
improvements in the composition of infant formulas hsve
reduced this difference [12]. Formula fed infants are also
characterized by the presence of species commonly found in
adults, such as Bifidobacterium adolescentis and Bifidobacterium
pseudocatenulatum, while breast-fed infants are colonized more
often with Bifidobacterium breve and B. infantis [13]. Bifidobacterium
bifidum and Bifidobacterium longum subsp. longum (B. longum), can be
found both in infants and adults [14].
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Human milk oligosaccharides (HMO) are abundant in breast
milk and they are thought to act as prebiotics selecting for specific
bacterial populations in the infant gut. They are characterized by a
lactose molecule at the reducing end to which subunits of lacto-N-
biose (LNB; type 1 chain; Galb1–3GlcNAc) or N-acetyl-lactosa-
mine (type 2 chain; Galb1–4GlcNAc) are attached in tandem [15].
Fucose and sialic acid residues can be located at terminal positions.
200 different HMO structures have been determined, however,
four molecular masses can represent up to the 70% of the total
molecules, including isomers of lacto-N-tetraose (Galb1–
3GlcNAcb1–3Galb1–4Glc; LNT), lacto-N-neotetraose (Galb1–
4GlcNAcb1–3Galb1–4Glc; LNnT), lacto-n-hexaose (LNH),
monofucosyl-lacto-N-hexaose and difucosyl lacto-N-hexaose
[16]. Interestingly, HMO structures resemble the lacto and
neolacto family of glycolipids [17], and polylactosamine chains
are characteristic in glycoproteins [18]. Mucin oligosaccharides
also share structural similarity with HMO [19].
Recently B. longum, B. infantis, B. breve and B. bifidum were
characterized by their capabilities for consuming HMO [20].
Particularly, a gene cluster for metabolism and import of LNB and
galacto-N-biose (Galb1–3GalNAc; GNB), a core substructure in
mucin glycans, is found in these microorganisms [21]. Also
enzymes involved in the deconstruction of HMO and the
metabolism of its constituents have been characterized [22,23].
Different strategies exist for HMO consumption. B. longum, B. breve
and B. bifidum seem to prefer LNT [24], and potentially rely on
extracellular glycosyl hydrolases for reduction of more complex
HMO as well as mucin glycans [25], while B. infantis apparently
has expanded its metabolic capabilities to use a higher variety of
HMO molecules, specializing in the import of complex carbohy-
drates and intracellular degradation [26]. The genome of this
bacterium has been recently sequenced [27], and several features
indicated a specialization in carbohydrate utilization. In addition
to the LNB/GNB cluster, B. infantis possesses two additional gene
clusters containing ABC transporters and glycosyl hydrolases
predicted to be involved in HMO utilization. These clusters were
also found to contain an important number of Family 1 Solute
Binding Proteins (F1SBPs), predicted to import oligosaccharides
associated to ABC transporters.
Genomic analysis suggests that B. infantis evolved from a plant-
derived glycan utilization genotype, to be competitive in the infant
colon [27]. Interestingly, all available carbon sources in this
environment are oligosaccharides from human origin, including a
significant concentration of HMO arriving undigested to the distal
colon, as well as intestinal secretions and glycoconjugates from
epithelial cells. The F1SBPs in B. infantis might be important to
understand the adaptations of this microorganism to the infant
gut, as well as the range of oligosaccharides it is able to import into
the cell and use as a carbon source. In this work we have
characterized B. infantis F1SBPs oligosaccharide affinities, expres-
sion during growth on different prebiotics and interactions with
epithelial cells in order to better understand the complex nature
for oligosaccharide foraging by this important intestinal species.
Results
Several B. infantis F1SBPs bind host glycans
The genome of B. infantis ATCC 15697 has twenty genes
containing the Pfam motif Sbp_bac_1, Family 1 of Solute Binding
Proteins (F1SBPs), with predicted affinity for oligosaccharides [3].
Their abundance in this genome is as much as twice compared to
other bifidobacterial genomes (Table 1). The F1SBPs genes from
B. infantis ATCC 15697 were PCR amplified, removing the
lipoprotein anchor sequences, and then cloned, expressed in
Escherichia coli and purified as glutathione-S-transferase (GST)
fusion proteins. The oligosaccharide binding properties of the
recombinant F1SBPs were analyzed using the Mammalian Glycan
Array v3.1 [28], provided by the Consortium for Functional
Glycomics. This version of the array contains more than 400
different glycans mainly present in mammalian cells. Eleven
F1SBPs from B. infantis bound at least one carbohydrate in this
array, suggesting a broad nutritional preference for host-derived
glycans. Figure 1 catalogs the glycans detected by these proteins
and their relative affinities (Table S2 list the oligosaccharides
present in the array).
The specificities of some F1SBPs narrowed to relatively few
substrates. For example, Blon_0375 bound solely to the trisaccha-
ride globotriose (Gala1–4Galb1–4Glc), while Blon_2444 was
found to have affinity for maltose. Blon_0343 and Blon_2202
share significant homology [27], and they both recognized two
related oligosaccharides: Fuca1–2Gal, the precursor for the ABO
blood group, and Fuca1–2Galb1–4Glc, 29 Fucosyl lactose (2FL).
These structures occur as epitopes in more complex glycans and
many were present in the array (Table S2), however these proteins
only recognized their free forms.
Other F1SBPs showed a broader and more flexible range of
glycans recognized in the array. Blon_0883 and Blon_2177 bound
type 1 glycans, characterized by the disaccharide Galb1–3GlcNAc
(LNB), as well as Galb1–3GalNAc (GNB), one of the core
substructures in mucin oligosaccharides. Interestingly, Blon_0883
also strongly bound to Lewis a and the type 1 H-trisaccharide, two
main epitopes present in glycolipids and glycoproteins in several
cell types including the intestinal epithelium [29,30,31]. However,
similarly to Blon_0343 and Blon_2202, Blon_0883 did not
recognize these structures as part of more complex oligosaccha-
rides. Blon_2177 also bound other type 1 polymers, such as LNT,
LNH, lacto-N-octaose (LNO), all abundant structures in HMO
[32], as well as other mammalian carbohydrates such as asialo
GM1 [33], the putative receptor for the Clostridium difficile toxin
TcdA [34], and sialyl-LNT [35], albeit the latter structures were
bound at a lower affinity (Figure 1).
B. infantis possesses a unique cluster of ABC transporters and
glycosyl hydrolases that was predicted to be important in the
Table 1. Representation of the Pfam01547 motif in
bifidobacterial genomes.
Sequenced genome Pfam01547 hits
Bifidobacterium adolescentis ATCC 15703 9
Bifidobacterium animalis lactis AD011 6
Bifidobacterium animalis subsp. lactis BB-12 5
Bifidobacterium animalis subsp. lactis Bl-04 6
Bifidobacterium bifidum NCIMB 41171 (Draft) 3
Bifidobacterium bifidum PRL2010 3
Bifidobacterium breve DSM 20213 (Draft) 16
Bifidobacterium catenulatum DSM 16992 (Draft) 11
Bifidobacterium dentium ATCC 27678 23
Bifidobacterium dentium Bd1 23
Bifidobacterium longum DJO10A 16
Bifidobacterium longum NCC2705 11
Bifidobacterium longum infantis ATCC 15697 20
Bifidobacterium pseudocatenulatum DSM 20438 (Draft) 15
doi:10.1371/journal.pone.0017315.t001
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HMO+ phenotype of this bacterium. This cluster contains 6
F1SBPs closely related at the sequence level [27]. Blon_2344 and
Blon_2347 specifically recognized type 2 glycans (Figure 1), binding
with different affinities linear and branched polylactosamines, as
well as lacto-n-neotetraose (LNnT) and difucosyl lacto-N-hexaose.
These structures are characteristic in HMO as well as in glycolipids
and glycoproteins [36]. These two F1SBPs also presented affinity for
complex neutral oligosaccharides found in human colonic mucins
[19] and thus are candidates for interaction with epithelial surfaces
and mucins. In the same gene cluster, Blon_2350, Blon_2351 and
Blon_2354 specifically detected GNB, supporting their role in
binding and/or import of mucin oligosaccharides. However, the
low affinity of these latter F1SBPs suggests that they may prefer
other glycans not present on the array.
F1SBP expression during growth on HMO
If F1SBPs are involved in binding and transport of complex
oligosaccharides to be used as a carbon and energy source in situ,
one would predict that their expression would be induced by the
presence of such glycans. To examine this, B. infantis cells were
grown on lactose, HMO, inulin, fructooligosaccharides (FOS) and
galactooligosccharides (GOS) as the only carbon sources, and the
relative expression level for each F1SBP was studied using qPCR.
The presence of these proteins inside the cells was also determined
using a proteomic approach.
Growth on HMO as the only carbon source induced the
expression of four F1SBP genes in the exponential phase,
Blon_0883, Blon_2344, Blon_2347 and Blon_2350 (‘‘induced’’
was defined as a minimum two-fold increase in gene expression;
Figure 2A). Proteomics also confirmed the expression of these
proteins (Table 2). These F1SBPs were not expressed in stationary
phase (Figure 2E). Given the affinities of these F1SBPs for HMO
structures, the expression results suggest that HMO induces
F1SBPs involved in its own import. Moreover, the predominant
HMO species consumed by B. infantis are consistent with the
glycans recognized by F1SBPs expressed during growth on HMO,
such as LNnT, LNnH and mono and difucosyl LNH [24]. Since
these four F1SBPs also recognized other oligosaccharides present
Figure 1. Oligosaccharides recognized by B. infantis F1SBPs in the Glycan Array v3.1. Oligosaccharides are attached to the array using
different spacer arms. Sp0: -CH2CH2NH2; Sp8: -CH2CH2CH2NH2; Sp10: -NHCOCH2NH; Sp21: -N(CH3)-O-(CH2)2-NH2. RFU: Relative Fluorescence Units.
Yellow circles, galactose; blue circles, glucose; yellow squares, N-Acetyl-galactosamine; blue squares, N-Acetyl-glucosamine; red triangles, fucose; pink
diamonds, sialic acid. ND: Not detected.
doi:10.1371/journal.pone.0017315.g001
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in mucins or glycoconjugates, the presence of HMO likely induces
the import of mucin and epithelial glycans and/or facilitates
adhesion of B. infantis to mucins or epithelial surfaces.
The relative gene expression for a number of HMO and mucin
binding F1SBPs was then determined using LNT and lacto-N-
neotetraose (LNnT), representative structures of type 1 and type 2
HMO respectively, and GNB as the only available carbon
sources. All four F1SBPs induced by HMO (Blon_0883,
Blon_2344, Blon_2347 and Blon_2350) showed an increase in
their expression during growth on LNT as well as LNnT
(Figure 2F) regardless of their own affinity for type 1 or type 2
chains as determined in the glycan array. This indicates that the
induction of proteins involved in HMO import does not depend
on the isomeric differences between Galb1–3GlcNAc and Galb1–
4GlcNAc in HMO.
Interestingly, Blon_2177 showed an increase in its relative gene
expression level with LNT and LNnT. However, this gene was not
induced during growth on the HMO pool (Figures 2A and 2E) nor
was it detected by shotgun proteomics (Table 2). This is expected
from its HMO affinities and its gene context (Figure 3A).
Figure 2. Gene expression of B. infantis F1SBPs growing under different prebiotics as the sole carbon source. Numbers in the x-axis
represent each F1SBP locus tag (Blon_). A: 2% HMO; B: 2% Inulin; C: 2% FOS; D: 2% GOS. Colored bars indicated F1SBPs with a change in gene
expression higher than two fold; E: relative expression levels for some HMO-induced genes in exponential (blue bars) and stationary phase (white
bars); F: relative expression levels for some F1SBPs under growth with GNB (purple bars), LNT (green bars) and LNnT (blue bars) as the only carbon
source. Levels for growth on lactose (white bars) are shown as a reference.
doi:10.1371/journal.pone.0017315.g002
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Changes in gene expression during growth on GNB were not as
dramatic as those induced by growth on LNT or LNnT, however
Blon_2344, Blon_2350 and Blon_2351 did exhibit an increase in
gene expression greater than two fold. The binding affinities for
these three F1SBPs indicated that they might be involved in the
import of intact mucin oligosaccharides as well of GNB.
A model summarizing the complex oligosaccharide binding
preferences of B. infantis growing on HMO is shown in Figure 4A.
Cells under these conditions could import intact type 1 chains by
Blon_2177, or via previous degradation by an extracellular lacto-
N-biosidase to LNB to be imported by Blon_0883. Fucosylated or
unfucosylated type 2 chains could also be transported in an intact
form into the bacterial cell. Some mucin oligosaccharides could be
imported directly into the cell, or after degradation by extracel-
lular glycosyl hydrolases that convert these oligosaccharides into
GNB. Some blood group epitopes could also be imported after
release from more complex carbohydrates. The import of these
molecules thereafter potentially provides the cell with monosac-
charides which can be used in central metabolic pathways by this
bacterium.
F1SBP expression during growth on other prebiotics
Growth on the commercial prebiotic inulin induced the
expression of seven F1SBPs (Figure 2B), however only four of
these proteins were witnessed in the B. infantis proteome (Table 2).
Several observations suggest that Blon_2061 is a candidate F1SBP
for the import of fructans in B. infantis. Firstly, this F1SBP did not
bind any glycan on the mammalian array. Additionally, the
neighboring gene Blon_2056 encodes a b-fructofuranosidase, and
a prominent homolog, BAD_1330, is located in a fructooligosac-
charide-utilization cluster in B. adolescentis (Figure S1). Interesting-
ly, Blon_2061 was the only F1SBP induced by FOS (Figure 2C).
This F1SBP does not have a homolog in B. longum subsp. longum
DJO10A, which suggests that oligofructose import occurs through
different transport systems in both strains.
Surprisingly, inulin increased the expression of B. infantis
F1SBPs that recognize mammalian glycans, including two proteins
present in the HMO Cluster 1 with affinities for GNB, and type 1
chain binding F1SBPs Blon_2177 and Blon_0883 (Figure 2B and
Table 2). These findings suggest a role for inulin inducing a
cellular response directed to the intestinal environment similar to
HMO, which include expression of F1SBPs involved in the import
of complex intestinal glycans. Besides fructans, cells growing on
inulin potentially import type 1 chains, GNB and some blood
group oligosaccharides, which after digestion to mono or
disaccharides by intracellular glycosyl hydrolases could be derived
to glycolytic pathways (Figure 4B).
Growth on GOS induced two different F1SBPs, Blon_2414 and
Blon_2458, which did not bind any of the mammalian glycans on
the CFG array (Figure 2D). Blon_2414 and Blon_2458 are located
close to a putative b-galactosidase (Blon_2416) and an a-
galactosidase (Blon_2460), respectively (Figure S1). Blon_2458 is
homolog to BL1521, a B. longum subsp. longum NCC2705 F1SBP
that was induced by raffinose [37]. Finally, Blon_2444 was found
to be induced by maltose (Figure S2), which is in concordance with
its affinity shown by the glycan array and a similar induction of a
homolog, BL0141, by maltose in B. longum subsp. longum [37].
In vitro interactions between F1SBPs and epithelial cells
Given that several of the F1SBPs exhibited adherence to glycans
commonly found on the epithelial cells, we hypothesized that these
binding proteins might also interact with intestinal epithelial
surfaces. To test this, B. infantis F1SBPs with affinity for
mammalian glycans (Figure 1) were labeled with FITC and
coincubated with differentiated Caco-2 cells, a human colonic
adenocarcinoma cell line. Using flow cytometry, a clear shift in the
mean fluorescence value was observed when cells were incubated
with Blon_2347 and Blon_0375 (Figures 5B–D), as well as with
Ulex Europeus Agglutinin lectin (UEA). This lectin is character-
ized by binding oligosaccharides containing the Fuca1–2Galb1–
4GlcNAc epitope. No fluorescence was detected when cells were
coincubated with other F1SBPs or FITC-streptavidin. These
observations were confirmed using confocal microscopy
(Figures 5E–I). Blon_2347 and Blon_0375 were found in the cell
membrane of fixed Caco-2 cells. When cells were fixed after
coincubation with Blon_0375, this particular protein was observed
in the cytoplasm of Caco-2 cells. (Figure 5H–I). Since this protein
binds globotriose, a glycolipid abundant in some cancer cell lines,
Table 2. Proteomic analysis of F1SBPs in B. infantis cells growing under different substrates.
Locus tag
(Blon_)a GOS FOS Inulin HMO
log(e)b Puniq
c SpCT
d %e log(e) Puniq SpCT % log(e) Puniq SpCT % log(e) Puniq SpCT %
0883 270.7 7 10 25 221.6 3 3 13
2061 2135.2 13 54 60 2193 18 131 75 23.2 1 1 7
2177 261 7 7 31
2344 263.9 7 15 29
2347 260.5 4 12 17
2350 229.5 1 1 6
2351 213 2 3 9
2354 24 1 3 6
2414 227.1 3 4 14
aOnly F1SBPs found in the proteome of B. infantis are shown.
bLog(e): protein probability BY X! Tandem.
cPuniq: a number of unique peptides used for the identification of a protein. Only the peptides with $22 were used.
dSpCT: a number of MS/MS spectra assigned for the identification of a protein.
e%: percentile of sequence coverage. Listed proteins have $95% of the protein probability by protein prophet algorithm when the peptides with $95% of probability
(by peptide prophet algorithm) were used.
doi:10.1371/journal.pone.0017315.t002
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it could be hypothesized that its internalization is mediated by this
glycolipid in cells expressing it in their cell membranes.
Discussion
In this work we have functionally characterized a family of
proteins in B. infantis predicted to import oligosaccharides as part
of ABC importers. Compared to related bifidobacterial genomes
these genes seem to be overrepresented in this subspecies (Table 1).
Using an array containing oligosaccharides abundant on mam-
malian cells, we determined that 10 out of 20 F1SBPs B. infantis
have affinity for mammalian glycans, including characteristic
HMO structures as well as intestinal glycoconjugates.
Patterns of F1SBP binding to host oligosaccharides
We observed two major trends in glycan binding. Blon_0343,
Blon_2202, Blon_0375, Blon_2350, Blon_2351 and Blon_2354
were specific for only one or two oligosaccharides in the glycan
array (Figure 1). Considering that these substrates were not
recognized by the same F1SBPs when they were present at
terminal or internal positions in more complex oligosaccharides, it
is likely that these proteins require their ligands to be in their free
forms. It is possible that the reducing end in these carbohydrates
might be critical for F1SBP binding. With the exception of
Blon_0375, none of the F1SBPs listed above were able to bind
epithelial Caco-2 cells, which are characterized by glycoconjugates
containing these epitopes (Figure 1 and Table S2). This idea
supports the role of these F1SBPs in oligosaccharide import
associated to ABC transporters, and suggests a requirement on
foreign extracellular glycosyl hydrolases for their release from
intestinal glycoconjugates and subsequent use as a carbon source
[38,39,40].
In contrast, Blon_0883, Blon_2177, Blon_2344 and Blon_2347
exhibited a more flexible capacity to bind either type 1 or type 2
chains on the glycan array. Because of this variable substrate
binding capacity it is possible to discern a core glycan epitope
interacting with the F1SBP binding pocket. An example is
Blon_2177, which binds the disaccharide Galb1–3HexNAc.
Additional LNB subunits can be attached to this disaccharide
structure, resulting however in a decrease in the RFU values for
this protein. Blon_0883 also prefers Galb1–3HexNAc, accepting a
fucose residue in either end of the disaccharide (Figure 1).
Blon_2344 and Blon_2347 both bind dilactosamine (Galb1–
4GlcNAcb1–3Galb1–4GlcNAcb) as a core structure. Modifica-
tions to this tetrasaccharide, such as additional lactosamine units,
fucose residues or replacing the terminal GlcNAc with glucose did
not inhibit binding. Additional studies are needed to determine to
what extent the substrates bound by F1SBPs are internalized into
the cell and how this interaction occurs at the structural level.
HMO import in B. infantis ATCC 15697
Blon_0883 and Blon_2177, the latter present in the LNB/GNB
gene cluster, were determined to bind type 1 glycans. In the glycan
array Blon_0883 had affinity for LNB as well as GNB, and it was
induced by HMO, LNT and LNnT. Blon_0883 is located in a
gene cluster that includes two enzymes predicted to participate in
hexosamine metabolism, glucosamine-6-P isomerase and glucos-
amine deacetylase (Figure 3B). Blon_0883 does not contain a
homolog in any other bifidobacterial genome sequenced to date.
Homologs are found in other members of the intestinal microbiota
such as Eubacterium rectale and Faecalibacterium prausnitzii. The gene
clusters in these microorganisms also contain homologs of
hexosamine metabolizing enzymes, as well as a LNB phosphor-
ylase, a key enzyme in the metabolism of type 1 chains [21].
Interestingly, B. longum DJO10A and NCC2705 possess a
structurally similar gene cluster containing enzymes related to
hexosamine metabolism (Figure 3B), however the transporter
protein is a homolog to OppA proteins, predicted to import
dipeptides (Family 5 of SBPs). As has been described previously for
pentose utilization [41], this difference is another example of how
B. infantis has adapted subspecies-specific mechanisms for HMO
and/or mucin metabolism, but which have diverged for
Figure 4. Oligosaccharide binding profile proposed for B. infantis cells growing on HMO (A) and inulin (B). Numbers represent each
F1SBP locus tag (Blon_).
doi:10.1371/journal.pone.0017315.g004
Figure 3. Genetic landscapes for Blon_2177 (A), Blon_0883 (B) and Blon_0343 (C), and close related homologs available in the
Integrated Microbial Genome database [72]. Percentages represent similarity of homolog genes to those in the B. infantis ATCC 15697 genome.
Locus tags are presented above each gene when available.
doi:10.1371/journal.pone.0017315.g003
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alternative purposes in the subspecies longum. In concordance with
this idea, only two of the ten F1SBPs with affinity with host glycans
have affinity to proteins in both B. longum sequenced genomes.
Blon_2177 is homologous to BL1638 in B. longum NCC2705.
Both are located in the LNB/GNB gene cluster that is well
conserved among Bifidobacterium species residing in the infant
gastrointestinal tract (Figure 3A). Homologs to this F1SBP are
present in all B. longum and B. infantis strains [42]. While BL1638
showed similar Kd values for GNB and LNB [43], Blon_2177
seems to prefer GNB three times more than LNB, being also able
Figure 5. Binding of F1SBPs to Caco-2 cells in vitro detected by flow cytometry (A–D) and confocal microcopy (E–F). A: FITC-
streptavidin; B and E: UEA-FITC 0.5 mg/ml; C: Blon_0375-FITC 1 mg/ml; D and F: Blon_2347-FITC 1 mg/ml; G: Blon_2347-FITC 1 mg/ml and DAPI (blue);
H: fixed Caco-2 cells coincubated with 1 mg/ml Blon_0375-FITC; I: Caco-2 cells incubated for 10 min with 1 mg/ml Blon_0375-FITC and stained with
DAPI.
doi:10.1371/journal.pone.0017315.g005
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to bind other complex structures such as LNT and LNH. These
structural differences may help explain the broader range of HMO
structures B. infantis is able to consume.
Blon_2177 expression was only detected when cells grew on
LNT and LNnT, and similarly to B. longum LMG 13197 [44], the
F1SBP in this cluster was induced by inulin. Contrary to what
might be predicted given its binding patterns, Blon_2177 was not
expressed during growth on HMO as indicated by qRT-PCR or
proteomics (Table 2). It is possible that the LNT concentration in
the pooled HMO preparation is not enough to induce the
expression of this protein, or certain HMO species repress its
expression. Considering that both Blon_2177 and Blon_0883 bind
type 1 chains, Blon_0883 might have a more active role in the
import of these structures. Blon_2177 could therefore be critical in
the import of non-fucosylated type 1 oligosaccharides, as well as
GNB (as a product of mucin glycan degradation). In order to
import type 1 HMO via Blon_0883, B. infantis needs to
deconstruct these glycans to the disaccharide LNB. Since a
lacto-N-biosidase gene has not been found in the B. infantis ATCC
15697 genome, it is possible that B. infantis relies on extracellular
degradation of type 1 HMO by other intestinal bacteria.
The ability to ferment LNB seems to be present among
relatively few bifidobacteria [45], and the import of this substrate
has been associated so far with a single F1SBP in the LNB/GNB
cluster already described. In B. infantis two F1SBPs were found to
bind LNB and five bind GNB (Figure 1). This suggests a particular
abundance of these two core structures in the infant colon, as well
as a selective pressure for mechanisms to internalize them. The
potential redundancy in these affinities correlates with the absence
of certain F1SBPs related to HMO import in some B. infantis
strains [42]. LNT is the main HMO isomer preferred by infant-
borne bifidobacteria [24]. B. bifidum was recently determined to
possess enzymes deconstructing type 2 chains such as LNnT [46],
however the role of these glycosyl hydrolases has not been tested in
vivo or their expression evaluated at the RNA or protein level. The
B. infantis ATCC 15697 genome contains a unique gene cluster
containing several transport related proteins and glycosyl hydro-
lases [27]. However as shown here, the F1SBPs in this cluster have
overlapping affinities, and bind different complex type 2 chains.
They can also interact with intact mucin oligosaccharides as well
as the core mucin structure GNB. It is probable that this entire
cluster is devoted to the deconstruction of this type of isomers,
while the aforementioned clusters Blon_0883 and Blon_2177
participate in type 1 chain metabolism. These findings are in
agreement with the preference for the import of complex
substrates for intracellular degradation in B. infantis [26],
contrasting with B. breve and B. bifidum, which seem to release
extracellular glycosyl hydrolases to break down type 1 oligosac-
charides to LNB and, potentially, metabolize type 2 oligosaccha-
rides [26,27]. One might predict that this strategy would be
applicable for structurally similar mucin and glycolipid oligosac-
charides as well.
Impact of F1SBP expression under growth on HMO or
inulin
While the binding behavior clearly predicted the types of
oligosaccharides that interact with a given F1SBP and associated
transport systems, the expression of these F1SBPs was not strictly
governed by growth on the cognate oligosaccharide partners.
Indeed, growth of B. infantis on inulin and HMO induced both
predicted transporters involved in their own import as well as
other, putatively unrelated F1SBPs. As depicted in Figure 2B,
F1SBPs induced by inulin, which is a fructose-based oligosaccha-
ride, import GNB into the cell, as well as type 1 chains and blood
group glycans. HMO-induced F1SBPs were determined to bind
HMO structures, but they can also import mucin oligosaccharides,
and blood group structures. These observations suggest an
adaptive response to two prebiotic substrates that reach the
human colon, and prepare bifidobacteria to encounter other host-
derived glycans. If so, an induction of other genes involved in host
oligosaccharide metabolism, such as glycosyl hydrolases, could be
expected. F1SBPs induced by HMO also showed binding to
epithelial cells. If their binding is one of the factors involved in B.
infantis adhesion to intestinal cells or mucins, HMO consumption
could indirectly help in bacterial attachment because of F1SBPs
dual function in the import and binding of intestinal oligosaccha-
rides.
Despite their similarities, growth on inulin resulted in induction
of a larger number of F1SBP than growth on FOS. This is a
surprising result given these fructans differ mostly in their degree
of polymerization (DP) (FOS, 2–7; inulin, 10–32). Inulin is also
characterized by branched chains. Shorter chain FOS and GOS
appeared to induce F1SBPs involved only in their import, in
contrast to HMO and inulin which induced additional F1SBPs
related to utilization, or binding, of intestinal glycans. These results
suggest that different prebiotics may elicit different binding and
colonization behaviors in commensal, or probiotic, bacteria in situ.
For some F1SBPs which affinities were determined in the glycan
array, the particular genes were not induced by any of the
substrates used. Blon_0343 and Blon_2202 showed affinity for
2FL and the H-disaccharide, however they were not expressed
either at the transcript or protein level under the conditions
studied. The localization of a fuconate dehydratase in the vicinity
of Blon_0343 supports the idea of their role in the import of
certain fucose containing oligosaccharides (Figure 3C). The
homolog of Blon_2015 (BL1163; Fig. S1) in B. longum NCC2705
was induced by lactose and GOS, however this was not observed
for B. infantis [37]. Further experiments are required to understand
the role of some F1SBPs which affinities or the conditions when
they are expressed are not clear. For example, Blon_2380 is
homologous to BL1330, a protein that was suggested to participate
in the import of mannose containing oligosaccharides [37].
Blon_0043 possesses several homologs in adult-type bifidobacteria,
and it is located in the same region that Blon_0047, which is a
putative xylan esterase.
F1SBPs and their role in host-bacterial interactions
HMO share structural similarity with intestinal glycoconjugates
and they prevent the binding of several pathogens to intestinal
surfaces [47,48,49]. One competitive advantage for B. infantis may
be the ability to both bind and consume HMO and other intestinal
glycoconjugates. Thus expression of specific F1SBPs in B. infantis
may play a role in acquisition of food substrates as well as assist in
adherence to glycoconjugates on epithelial surfaces. SBPs from
certain microorganisms have been found to be associated with
bacterial adhesion [50,51].
Cultured epithelial cells have been shown to be mostly
unresponsive to B. infantis [52]. However, B. infantis is able to
downregulate the cytokine induction profile from some gastroin-
testinal pathogens [53]. B. infantis has also been shown to secrete
products that enhance epithelial cell function [54]. Candidates for
adhesion and interaction with the epithelium found in other
bifidobacteria or lactobacilli such as glycoprotein binding fimbriae
or mucus binding proteins were not observed in the genome of B.
infantis ATCC 15697 [27]. F1SBPs binding specific glycoconju-
gates in epithelial cells remain as candidates for these functions.
Some oligosaccharides detected by F1SBPs are commonly found
in epithelial cell membranes or occur as glycoconjugates in
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mucins. For example, Lewis a is one of the most abundant
glycolipids in intestinal epithelial cells [55], and it was one of the
ligands bound by Blon_0883. Polylactosamines are also common
structures abundant in the complex type of N-linked proteins, as
well as in glycolipids, especially in erythrocytes and neutrophiles
[56]. Blon_2344 and Blon_2347 possessed an exquisite affinity for
these structures and might be important in host-bacterial
interactions. Polylactosamines are also one of the binding targets
for several pathogens, such as Helicobacter pylori [57], and the heat-
labile enterotoxin of E. coli [58]. Therefore, the expression of these
particular F1SBPs might prevent in some cases bacterial
colonization or toxin intoxication via competitive exclusion.
In the glycan array, Blon_0375 was highly specific for
globotriose (Gb3), a trisaccharide usually conjugated to ceramide,
and it appeared to be internalized by a discrete population of
Caco-2 cells. This glycan has been found at low concentrations in
human milk [59] and is characteristic of the urothelial epithelium
[60] and human fetal meconium [61]. Blon_0375 binding Gb3
might provide a competitive advantage to this bacterium, and
suggests that this oligosaccharide must be abundant in the
environment where B. infantis resides. This protein could also be
important in bacterial adhesion and interaction with intestinal
epithelial cells. Gb3 is not abundant in adult epithelial cells, and
no detailed description exists on the abundance of this glycolipid in
the human intestinal mucosa in the first months of life. However,
Gb3 is highly expressed in several cancer cell lines, and in
particular during metastasis. Globotriose is also the target for the
B-subunit of the Shiga toxin [62], and it has been successfully
studied as an effector against tumors in vivo [63,64].
Bifidobacteria are well-adapted microorganisms that cohabitate
the lower section of the gastrointestinal tract, to which several
health benefits have been attributed [65,66]. As has been observed
with some Bacteroides species, bifidobacteria have been character-
ized by their ability to utilize complex oligosaccharides, mainly
plant-derived but also host-derived such as HMO [67,68]. The
existence of discrete molecular mechanisms for the import of these
complex structures in bifidobacteria suggests an evolutionary
adaptation to the presence of these indigestible dietary oligosac-
charides in the human colon. Indeed, the induction of some
common F1SBPs between inulin and HMO suggests a common
regulatory mechanism. Since genomic analysis suggests B. infantis
has displaced some plant-associated sugar catabolism genes with
genes for milk sugars [41] it could be argued that the regulation of
HMO consumption has simply adapted from an existing inulin-
based regulon.
Defining the details of the intricate tripartite network between
human milk, the developing infant intestinal epithelium and the
intestinal microbiota is critical for understanding the biology of the
microbial foundation process occurring in the first years of life in
the infant gut, as well as for the improvement of infant formulas.
In particular, understanding the nutritional preferences for
complex oligosaccharides for members of the microbiota will help
in the future in the selection of specific desirable probiotic strains,
as well as a change towards more specific prebiotic compounds.
Materials and Methods
Bacteria and media
B. longum subsp. infantis ATCC 15697 was obtained from the
American Type Culture Collection (Manassas, VA). Cultures were
routinely grown using Mann Rogose Sharp medium with no
carbon source, and supplemented with 2% w/v lactose and 0.25%
w/v L-cysteine (Sigma-Aldrich, St. Louis, MO). Bacteria were
routinely cultured in a vinyl anaerobic chamber (Coy Laboratory
Products, Grass Lake, MI) at 37uC. Chemically competent
Escherichia coli BL21 and DH5a were obtained from EMD
Chemicals (Gibbstown, NJ), and grown in Luria Broth supple-
mented with 50 mg/ml ampicilin (Sigma-Aldrich, St. Louis, MO)
when necessary at 37uC.
F1SBP Cloning and Expression
Genes coding for F1SBPs were described by [27]. Gene features
such as lipoprotein attachment site and signal peptide sequence
were identified using the Biology workbench 3.2 (http://
workbench.sdsc.edu). PCR primers were designed to target each
gene excluding the signal peptide region. Primers sequences were
designed with different 59 restriction sites, and an extra six base
pairs for proper enzyme restriction digestion (Table S1). Genomic
DNA from B. infantis was purified from 2 ml cultures using the
MasterPureTM Gram Positive DNA Purification Kit (Epicentre
Biotechnologies, Madison, WI), following the manufacturer
instructions. F1SBP genes were amplified by PCR using 0.5 mM
of each forward and reverse primer, 1 ng genomic DNA, 0.2 mM
dNTP mix (Fermentas, Glen Burnie, MD), and 2 U of PFU Turbo
DNA polymerase (Stratagene, Cedar Creek, TX) in a 100 ml final
volume. PCR was performed using a PTC200 Thermo Cycler (MJ
Research, Ramsey, MN), with an initial denaturation at 95uC for
2 min, and 35 cycles of denaturation at 95uC 1 min, annealing at
58uC for 1 min, extension at 72uC 2 min, and a final extension at
72uC for 7 min. PCR products were gel purified and digested with
two restriction enzymes (Fermentas, Glen Burnie, MD), which
cleaved the sequences shown in bold in Table S1. The expression
plasmid pGEX-6P-1 (Glutathione-S-Transferase Gene Fusion
System, GE Healthcare, Piscataway, NJ), was linearized with the
same two enzymes for each PCR product and dephosphorylated
using Antarctic Phosphatase (New England Biolabs, Ipswich, MA),
and ligated to each F1SBP gene in a 1:3 ratio using 1 U of T4
DNA ligase (Promega, Madison, WI), in a 10 ml final volume at
4uC overnight. Ligation reactions were transformed into E. coli
BL21 and DH5 chemically competent cells at 42uC for 30 sec and
allowed to recover for 1 h at 37uC in SOC media (Invitrogen).
Recombinant clones were selected for growth on LB agar with
50 mg/ml ampicilin, and confirmed by plasmid sequencing using
primers pGEX 5 and pGEX 3 (GE Healthcare). Protein
expression was carried out using 100 ml LB broth supplemented
with 50 mg/ml ampicilin. Cells were grown at 37u in a shaker at
250 rpm (Innova-4000, New Brunswick Scientific, Edison, NJ),
until they reached an O.D. of 0.6 when they were supplemented
with 1 mM IPTG (Fermentas) for 2 h. In some cases due to low
protein solubility, cultures were scaled to 2 L and growth was
performed at 28uC. Cells were collected in an Eppendorf 5804
centrifuge (Eppendorf, Hauppauge, NY) 20 min at 4u and at
4000 rpm, and stored at 280uC at least for 18 h. Pellets were
resuspended in Bugbuster Protein Extraction Reagent (EMD
Chemicals), using 1 ml of the detergent for 20 ml of the original
culture, and incubated for 20 min at room temperature. The
suspension was centrifuged for 20 min at 13200 rpm at 4uC, and
the supernatant was applied to 1 ml Bio-Scale Mini Profinity GST
cartridges, connected to an EP-1 Econo-pump (Bio-Rad, Hercules,
CA). Protein purification was performed as recommended by the
manufacturer. Recombinant proteins were evaluated for molecu-
lar weight and purity in SDS-PAGE gels. Finally, glutathione was
exchanged for PBS buffer using Amicon Ultra-15 Centrifugal
Filter Units, with a cut-off of 50 kDa (Millipore, Billerica, CA).
Glycan Array Analysis
Each GST-tagged F1SBP was screened for glycan interactions
by the Core H of the Consortium for Functional Glycomics, using
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versions 3.1 and up of the Glycan Array. Each protein sample was
diluted to 200 mg/ml in binding buffer (20 mM Tris-HCL pH 7.4,
150 mM sodium chloride, 2 mM calcium chloride, 2 mM
magnesium chloride, 0.05% Tween 20 and 1% BSA), and assayed
to printed glycan slides. Binding and detection were carried out
using an anti-GST Alexa 488 conjugate antibody (Molecular
Probes, Eugene, OR). Results were expressed as Relative
Fluorescent Units (RFU), and the highest and lowest point from
each set of six replicates were removed.
RNA Extraction
B. infantis ATCC 15697 was grown at 37uC under anaerobic
conditions on 15 ml of ZMB1 media [69], supplemented in
different triplicate experiments with 2% of either lactose, glucose,
fructooligosaccharides (FOS, raftilose Synergy 1, Orafti, Malvern,
PA), galactooligosaccharides (GOS, Purimune, GTC Nutrition,
Golden, CO), inulin (raftiline HP, Orafti, Malvern, PA), or
purified HMO [70]. Also, lacto-N-tetraose, lacto-N-neotetraose
and galacto-N-biose (V-Labs, Covington, LA) were supplemented
at 0.5% to the ZMB media. Optical density was assayed using a
PowerWave microplate spectrophotometer (BioTek Instruments,
Inc., Winoosky, VT). Cultures were recovered at exponential and
stationary phase, as defined by previously obtained growth curves.
Cells were immediately pelleted and resuspended in 1 ml of RNA
later (Ambion, Austin, TX), and stored overnight at 4uC and then
at 280uC until use. Bacterial cells were washed twice with PBS
buffer, and pre-lysed with 250 ml of 50 mg/ml lysozyme and
120 ml of mutanolysin at 1000 units/ml (Sigma-Aldrich). Total
RNA was extracted using the Ambion RNAqueous kit. Briefly,
cells were resuspended in 300 ml of Lysis/Binding solution, and
vortexed for 10 sec. After adding 300 ml of 64% ethanol, the lysate
was transferred to RNAse-free filter cartridges, and washed with
700 ml of wash solution 1, and twice with 500 ml of wash solution
2/3. RNA was eluted with 50 ml of elution solution twice. RNA
was further purified using the Qiagen RNeasy kit. 350 ml of Buffer
RLT were added to the RNA obtained, and then 250 ml ethanol
were also mixed. The sample was applied to an RNeasy column
centrifuged. The columns were washed with 500 ml Buffer RPE
twice, and the RNA was eluted with 50 ml RNase-free water done
twice. Finally, the RNA was concentrated adding 50 ml LiCl to the
RNA, and incubated at 270uC for 48 h, washed with cold 70%
ethanol and resuspended in 20 ml DNAse/RNAse–free water.
RNA concentration was evaluated by absorbance at 260 nm
(Nanodrop, Thermo Scientific, Wilmington, DE). Acceptable
RNA ratios were A260/A280$1.8, and A260/A230$1.5. RNA
was checked for integrity in an Agilent Bioanalyzer 2100 with the
RNA 6000 Nano Kit (Agilent Technologies, Foster City, CA).
Quantitative Real-Time PCR
The relative levels of gene expression for each F1SBP gene
under growth with different carbon sources were evaluated by
quantitative PCR. The gene Blon_0393, encoding a cysteinyl-
tRNA synthetase, was chosen as an endogenous control [71].
Primers and 59 nuclease probes were designed and synthesized by
TibMolBiol (Adelphia, NJ) (Table S1). qPCR was performed in a
7500 Fast Real-Time PCR System using the Taqman One-Step
RT-PCR kit (Applied Biosystems, Foster City, CA). Every reaction
contained primers at 0.5 mM, each probe at 125 nM, 5 ng of
RNA and Reverse Transcriptase and reaction buffer as recom-
mended by the manufacturer. Gene expression for each gene
under the different conditions representing different carbon
sources was evaluated by Relative Standard Curves, both for the
endogenous control and each gene on each plate. qPCR reactions
were run at 48uC for 30 min, then 95uC for 10 min, and 40 cycles
with denaturation at 95uC for 15 sec and annealing and
elongation for 1 min at 60uC. Threshold cycle data and relative
efficiencies were analyzed using the Q-Gene software (www.gene-
quantification.de/qgene.zip). Gene expression levels for growth
on lactose were used as the calibrator. Results were expressed as
fold changes in gene expression.
Proteomics of B. infantis F1SBPs
B. infantis cultures growing under different substrates and used for
RNA extraction were also taken at exponential phase, and
normalized to an OD600 of 1.0 by dilution or concentration. Upon
centrifugation, 15 ml of each sample were washed three times with
PBS vigorously. Cell pellets were resuspended in 600 ml of lysis
buffer containing 100 mM Tris and 8.0 M urea. Cells were
mechanically lysed using silica beads and a bead-beater (FastPrep,
QBiogene, Carlsbad, CA, USA) for eight cycles of 30 s pulses each
with a 30 s interval on ice. Beads and cell debris were removed by
centrifugation and the soluble fraction was stored at 280uC for
further analysis. Protein concentration was measured with the
Protein Assay Kit (BioRad, Hercules, CA, USA). A volume of
200 mg/ml of protein was transferred to a new cap tube and
precipitated by ethanol (75% (v/v)) at220uC. Upon centrifugation,
protein pellets were resuspended in 100 ml of 0.1 M Tris/1 M urea
buffer (pH 8.0). Proteins were then digested with 5 mg of mass
spectrometry grade trypsin (Promega, Madison, WI, USA)
overnight at 37uC. The tryptic peptides were purified using Cap
Trap Columns for peptide concentration and a Desalting Cartridge
(Michrom, Aurburn, CA, USA) according to the manufacturer’s
manual. The peptides were eluted in 98% acetonitrile in water and
then dried prior to mass spectrometry analysis.
The digested protein samples were submitted to the Genome
Center Proteomics Core at the University of California, Davis.
Protein identification was performed using an Eksigent Nano LC 2-
D system coupled to an LTQ ion-trap mass spectrometer (Thermo-
Fisher, Waltham, MI, USA) using a Picoview nano-spray source.
Peptides were loaded onto a nanotrap (Zorbax 300 SB-C18, Agilent
Technologies, Santa Clara, CA, USA) at a loading flow rate of
5.0 ml/min. Peptides were then eluted from the trap and separated at
a level of nano-scale using a 75 mm615 cm New Objectives Picofrit
Column packed in-house. The top ten ions in each survey scan were
subjected to automatic low-energy CID. Tandem mass spectra were
extracted and the charge states deconvoluted by BioWorks version
3.3. All MS/MS samples were analyzed using X! Tandem (GPM-
XEmanager, ver. 2.2.1). X! Tandem was set up to search against the
B. infantis ATCC 15697 whole proteome. X! Tandem was searched
with a fragment ion mass tolerance of 0.60 Da. Oxidation of
methionine was specified as a variable modification in X! Tandem.
Cutoff of log(e) for the peptide (log(e)) was set ,22 and the protein
with the log(e) ,26 was considered to be present.
F1SBP in vitro binding to Caco-2 cells
Recombinant F1SBPs were purified as described previously,
and labeled using the Fluoreporter FITC Protein Labeling Kit
(Molecular Probes) as recommended by the manufacturer. Caco-2
cells were obtained from the American Type Culture Collection,
and routinely cultured in DMEM supplemented with 10% Fetal
Bovine Serum, 10 mM HEPES and 1% Penicillin-Streptomycin
(Invitrogen, Carlsbad, CA) on 75 cm2 flasks and incubated at 37u
with 5% CO2. Cells were routinely passed to new flasks using
0.25% trypsin (Invitrogen) two weeks after confluence. For flow
cytometry experiments, trypsinized Caco-2 cells were fixed in 4%
paraformaldehyde (PFA, Sigma-Aldrich), and after two washes
with PBS, they were incubated with different concentrations of
labeled F1SBPs in PBS buffer or UEA-FITC lectin (Vector
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laboratories, Burlingame, CA) at 37uC for 1 h. Cells were
centrifuged at 3000 x g 4 min, and washed four times with PBS-
tween 0.05%. Lectin-labeled cells were analyzed by flow
cytometry using a Becton Dickinson FACScan Flow Cytometer.
30000 events for each sample were recorded using FSC, SSC and
an argon laser at 488 nm emission. Fluorescence was measured at
515/540 nm excitation, and analyzed using the CellQuest
software. For confocal microscopy, Caco-2 cells were seeded in
eight-well chamber slides (Nalgene Nunc International, Naper-
ville, IL), and after two weeks post-confluence they were washed
with PBS and fixed with PFA 4% for 20 min. After two washes
with PBS, monolayers were incubated with different concentra-
tions of FITC-labeled F1SBPs or UEA-FITC lectin, and incubated
at 37uC 1 h. After four washes with PBS 1X, slides were
permeabilized with 0.1% Triton X-100 and incubated with
0.1 ng/ml 49,6-diamidino-2-phenylindole (DAPI, Invitrogen,
Carlsbad, CA), and finally covered with VectaShield Mounting
Medium (Vector laboratories, Burlingame, CA). In some cases
Caco-2 monolayers were incubated with F1SBPs for 10 or 30
minutes and then cells were fixed and processed as indicated.
Slides were analyzed with an Olympus FV1000 Laser Scanning
Confocal microscope (Olympus, Melville, NY).
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